The global microbiology testing market size was estimated to be USD 5.48 billion in 2023 and is expected to reach at USD 15.17 billion by 2034 with a CAGR of 9.70% during the forecast period 2024-2034. Increasing technological advancements in microbiology testing, growing prevalence of infectious diseases, surge in funding for research by private & government bodies, rising healthcare expenditure, rising launch of innovative testing products, increasing development & expansion of healthcare sector, growing research & development activities, and surge in acquisitions within market players for the development of innovative microbiology testing products are some of the key factors boosting the market growth.
Surge in acquisitions within market players for the development of innovative microbiology testing products is predicted to grow at fastest CAGR during the forecast period. For instance, in November 2022, IDEXX purchased Tecta-PDS, a pioneering Canadian firm that has brought automation to the field of water microbiology assessment, encompassing elements such as E. coli and total coliforms. This acquisition enabled IDEXX to broaden its array of choices for water microbiology testing, catering to both lab-based and on-site testing needs.
By product, instruments was the highest revenue-grossing segment in the global microbiology testing market in 2023 owing to increased testing volume, quick & precise findings, growing need for equipment with high throughput and automation capability to process numerous samples rapidly, rising technical advancements in the areas of molecular techniques & proteomics, surge in acceptance of conventional laboratory instruments by academics & researchers, and increasing initiatives by market players. For instance, in June 2022, STEMart, an integrated Contract Research Organization (CRO) for medical devices, provides comprehensive sterility and microbial testing services for products that are free from pyrogens. STEMart is dedicated to advancing the clinical progress of medical devices and diagnostic tools. The company maintains its commitment to delivering end-to-end support to manufacturers in achieving regulatory objectives and mitigating adherence uncertainties. Additionally, reagents is predicted to grow at fastest CAGR during the forecast period owing to the growing demand for advanced products and rising focus on development of innovative products.
By test, bacterial was the highest revenue-grossing segment in the global microbiology testing market in 2023 owing to the high prevalence of bacteria-related food poisoning, stringent regulations for bacterial contamination in food and beverage production, and increasing technological developments by major market players. For instance, in June 2022, According to EMSL Analytical, Inc, their Houston branch offers Polymerase Chain Reaction (PCR) testing for the Legionella and Bacteroides genera. PCR is a technique that magnifies short DNA segments. The Houston facility is a proficient entity in performing microbiological analyses for elements like molds, bacteria, contaminants present in wastewater, E. coli, overall coliform levels, foodborne pathogens, and more. Additionally, viral is predicted to grow at fastest CAGR during the forecast period owing to the surge in prevalence of viral infections and growing technological advancements for the development of advanced viral testing products.
By application, diagnostics was the highest revenue-grossing segment in the global microbiology testing market in 2023 owing to rising prevalence of infectious diseases, growing healthcare expenditure, increasing emphasis on effective & early disease diagnosis, surge in introduction of advanced, accurate, & rapid methods for faster clinical diagnosis, and rising launch of new products by market players. For instance, in April 2022, DCN Dx, a point-of-use test manufacturer and developer in the United States, has completed the acquisition of Biomed Diagnostics, a microbiological testing company also based in the US. The financial details of the acquisition remain undisclosed, but it is expected to significantly broaden DCN Dx's presence in the point-of-use testing and sampling sectors for both human and animal applications. Additionally, pharmaceutical is predicted to grow at fastest CAGR during the forecast period owing to the several uses for microbiological testing in the identification of illnesses like respiratory problems, bloodstream infections, gastrointestinal problems, periodontal disorders, & urinary tract infections, among others and rising technological advancements in microbial testing.
By end-user, hospitals & diagnostic centres was the highest revenue-grossing segment in the global microbiology testing market in 2023 owing to increasing prevalence of infectious diseases, rising technological developments in microbiology testing automation, and growing focus on expansion by major market players. For instance, in November 2022, Archer Daniels Midland (ADM) inaugurated a new microbiology lab at its ADM Specialty Manufacturing site located in Decatur, Illinois. This initiative resulted in a twofold increase in the laboratory space dedicated to microbiology and an augmentation of the facility's testing capacities. Additionally, academic & research institutes is predicted to grow at fastest CAGR during the forecast period owing to the rising prevalence of infectious diseases and growing research & b development activities for the development of novel microbial testing products.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in prevalence of infectious diseases, rising technological advancements in microbiology testing, the presence of leading market players, increasing investment in research by the government, and growing establishment of the facilities for the accessibility of testing. For instance, in March 2022 Bureau Veritas has introduced a microbiology lab in Canada, providing Rapid Pathogen Testing and Indicator services. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing government programs to enhance awareness & supportive regulatory measures to boost the uptake of microbiological testing, surge in sophisticated diagnostic techniques, growing need for high-quality healthcare, and rising initiatives by major market players. For instance, in July 2022, Merck has unveiled its inaugural Microbiology Application and Training (MAT) Lab in Jigani, Bengaluru. This facility will provide resources and expert guidance to assist the life science community in India in enhancing their capabilities for microbial quality control.
Surge in acquisitions within market players for the development of innovative microbiology testing products is predicted to grow at fastest CAGR during the forecast period. For instance, in November 2022, IDEXX purchased Tecta-PDS, a pioneering Canadian firm that has brought automation to the field of water microbiology assessment, encompassing elements such as E. coli and total coliforms. This acquisition enabled IDEXX to broaden its array of choices for water microbiology testing, catering to both lab-based and on-site testing needs.
By product, instruments was the highest revenue-grossing segment in the global microbiology testing market in 2023 owing to increased testing volume, quick & precise findings, growing need for equipment with high throughput and automation capability to process numerous samples rapidly, rising technical advancements in the areas of molecular techniques & proteomics, surge in acceptance of conventional laboratory instruments by academics & researchers, and increasing initiatives by market players. For instance, in June 2022, STEMart, an integrated Contract Research Organization (CRO) for medical devices, provides comprehensive sterility and microbial testing services for products that are free from pyrogens. STEMart is dedicated to advancing the clinical progress of medical devices and diagnostic tools. The company maintains its commitment to delivering end-to-end support to manufacturers in achieving regulatory objectives and mitigating adherence uncertainties. Additionally, reagents is predicted to grow at fastest CAGR during the forecast period owing to the growing demand for advanced products and rising focus on development of innovative products.
By test, bacterial was the highest revenue-grossing segment in the global microbiology testing market in 2023 owing to the high prevalence of bacteria-related food poisoning, stringent regulations for bacterial contamination in food and beverage production, and increasing technological developments by major market players. For instance, in June 2022, According to EMSL Analytical, Inc, their Houston branch offers Polymerase Chain Reaction (PCR) testing for the Legionella and Bacteroides genera. PCR is a technique that magnifies short DNA segments. The Houston facility is a proficient entity in performing microbiological analyses for elements like molds, bacteria, contaminants present in wastewater, E. coli, overall coliform levels, foodborne pathogens, and more. Additionally, viral is predicted to grow at fastest CAGR during the forecast period owing to the surge in prevalence of viral infections and growing technological advancements for the development of advanced viral testing products.
By application, diagnostics was the highest revenue-grossing segment in the global microbiology testing market in 2023 owing to rising prevalence of infectious diseases, growing healthcare expenditure, increasing emphasis on effective & early disease diagnosis, surge in introduction of advanced, accurate, & rapid methods for faster clinical diagnosis, and rising launch of new products by market players. For instance, in April 2022, DCN Dx, a point-of-use test manufacturer and developer in the United States, has completed the acquisition of Biomed Diagnostics, a microbiological testing company also based in the US. The financial details of the acquisition remain undisclosed, but it is expected to significantly broaden DCN Dx's presence in the point-of-use testing and sampling sectors for both human and animal applications. Additionally, pharmaceutical is predicted to grow at fastest CAGR during the forecast period owing to the several uses for microbiological testing in the identification of illnesses like respiratory problems, bloodstream infections, gastrointestinal problems, periodontal disorders, & urinary tract infections, among others and rising technological advancements in microbial testing.
By end-user, hospitals & diagnostic centres was the highest revenue-grossing segment in the global microbiology testing market in 2023 owing to increasing prevalence of infectious diseases, rising technological developments in microbiology testing automation, and growing focus on expansion by major market players. For instance, in November 2022, Archer Daniels Midland (ADM) inaugurated a new microbiology lab at its ADM Specialty Manufacturing site located in Decatur, Illinois. This initiative resulted in a twofold increase in the laboratory space dedicated to microbiology and an augmentation of the facility's testing capacities. Additionally, academic & research institutes is predicted to grow at fastest CAGR during the forecast period owing to the rising prevalence of infectious diseases and growing research & b development activities for the development of novel microbial testing products.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in prevalence of infectious diseases, rising technological advancements in microbiology testing, the presence of leading market players, increasing investment in research by the government, and growing establishment of the facilities for the accessibility of testing. For instance, in March 2022 Bureau Veritas has introduced a microbiology lab in Canada, providing Rapid Pathogen Testing and Indicator services. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing government programs to enhance awareness & supportive regulatory measures to boost the uptake of microbiological testing, surge in sophisticated diagnostic techniques, growing need for high-quality healthcare, and rising initiatives by major market players. For instance, in July 2022, Merck has unveiled its inaugural Microbiology Application and Training (MAT) Lab in Jigani, Bengaluru. This facility will provide resources and expert guidance to assist the life science community in India in enhancing their capabilities for microbial quality control.
Segmentation: Microbiology Testing Market Report 2022 - 2033
Microbiology Testing Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Bn)
- Reagents
- Instruments
Microbiology Testing Market Analysis & Forecast by Test 2023 - 2034 (Revenue USD Bn)
- Viral
- Bacterial
- Fungal
Microbiology Testing Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Pharmaceutical
- Diagnostic
- Food & Beverage Testing
- Environmental
- Cosmetic
- Others
Microbiology Testing Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Hospitals & Diagnostic Centres
- Custom Lab Service Providers
- Academic & Research Institutes
Microbiology Testing Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Microbiology Testing Market: Product Estimates & Trend Analysis
8. Microbiology Testing Market: Test Estimates & Trend Analysis
9. Microbiology Testing Market: Application Estimates & Trend Analysis
10. Microbiology Testing Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Microbiology Testing Market
13. Europe Global Microbiology Testing Market
14. Asia Pacific Global Microbiology Testing Market
15. Latin America Global Microbiology Testing Market
16. MEA Global Microbiology Testing Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Biotrack Bv
- Abbott Laboratories
- Aquagenx LLC
- Becton Dickinson and Company
- 3M Company
- F. Hoffmann-La Roche Ltd
- Avantor Performance Materials LLC
- Bruker Corporation
- Danaher Corporation
- Hologic Corporation
- Agilent Technologies Inc.
- Thermo Fisher Scientific Inc.
- Accepta Ltd
- Merck KGaA
- Biomrieux SA
- Shimadzu Corporation
- Bio-Rad Laboratories Inc.
- NEOGEN Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | October 2023 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 5.48 Billion |
| Forecasted Market Value ( USD | $ 15.17 Billion |
| Compound Annual Growth Rate | 9.7% |
| Regions Covered | Global |
| No. of Companies Mentioned | 18 |
